News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
480,444 Results
Type
Article (25224)
Company Profile (160)
Press Release (455053)
Multimedia
Podcasts (46)
Webinars (14)
Section
Business (125544)
Career Advice (501)
Deals (20714)
Drug Delivery (53)
Drug Development (79558)
Employer Resources (44)
FDA (12803)
Job Trends (9397)
News (235800)
Policy (18896)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (1733)
Academic (1)
Accelerated approval (27)
Adcomms (29)
Allergies (132)
Alliances (34011)
ALS (171)
Alzheimer's disease (1643)
Antibody-drug conjugate (ADC) (306)
Approvals (13112)
Artificial intelligence (482)
Autoimmune disease (147)
Automation (32)
Bankruptcy (149)
Best Places to Work (8262)
BIOSECURE Act (12)
Biosimilars (146)
Biotechnology (120)
Bladder cancer (155)
Brain cancer (59)
Breast cancer (635)
Cancer (4703)
Cardiovascular disease (378)
Career advice (447)
Career pathing (19)
CAR-T (274)
CDC (11)
Celiac Disease (2)
Cell therapy (699)
Cervical cancer (36)
Clinical research (69468)
Collaboration (1570)
Company closure (3)
Compensation (973)
Complete response letters (43)
COVID-19 (2154)
CRISPR (82)
C-suite (732)
Cystic fibrosis (138)
Data (6145)
Decentralized trials (2)
Denatured (21)
Depression (134)
Diabetes (433)
Diagnostics (5458)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (17)
Drug discovery (222)
Drug pricing (53)
Drug shortages (13)
Duchenne muscular dystrophy (202)
Earnings (51926)
Editorial (24)
Employer branding (3)
Employer resources (43)
Events (78510)
Executive appointments (880)
FDA (15686)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (21)
Funding (1352)
Gene editing (181)
Generative AI (43)
Gene therapy (531)
GLP-1 (733)
Government (2398)
Grass and pollen (6)
Guidances (321)
Healthcare (13929)
HIV (47)
Huntington's disease (47)
IgA nephropathy (81)
Immunology and inflammation (222)
Immuno-oncology (48)
Indications (99)
Infectious disease (2366)
Inflammatory bowel disease (192)
Inflation Reduction Act (5)
Influenza (100)
Intellectual property (212)
Interviews (70)
IPO (11241)
IRA (13)
Job creations (1508)
Job search strategy (389)
JPM (29)
Kidney cancer (16)
Labor market (36)
Layoffs (327)
Leadership (16)
Legal (2352)
Liver cancer (82)
Longevity (13)
Lung cancer (629)
Lymphoma (362)
Machine learning (34)
Management (14)
Manufacturing (546)
MASH (156)
Medical device (9724)
Medtech (9768)
Mergers & acquisitions (10442)
Metabolic disorders (1030)
Multiple sclerosis (151)
NASH (14)
Neurodegenerative disease (312)
Neuropsychiatric disorders (79)
Neuroscience (2812)
Neurotech (1)
NextGen: Class of 2026 (3920)
Non-profit (2475)
Now hiring (38)
Obesity (424)
Opinion (180)
Ovarian cancer (161)
Pain (191)
Pancreatic cancer (224)
Parkinson's disease (278)
Partnered (24)
Patents (405)
Patient recruitment (489)
Peanut (53)
People (39103)
Pharmaceutical (36)
Pharmacy benefit managers (8)
Phase 1 (22358)
Phase 2 (30908)
Phase 3 (22427)
Pipeline (4816)
Policy (99)
Postmarket research (2070)
Preclinical (8101)
Press Release (29)
Prostate cancer (230)
Psychedelics (40)
Radiopharmaceuticals (273)
Rare diseases (765)
Real estate (2935)
Recruiting (17)
Regulatory (17950)
Reports (26)
Research institute (1902)
Resumes & cover letters (70)
Rett syndrome (27)
RNA editing (13)
RSV (50)
Schizophrenia (134)
Series A (238)
Series B (183)
Service/supplier (8)
Sickle cell disease (85)
Special edition (14)
Spinal muscular atrophy (151)
Sponsored (27)
Startups (2427)
State (1)
Stomach cancer (15)
Supply chain (67)
Tariffs (15)
The Weekly (25)
Vaccines (714)
Venture capital (56)
Weight loss (235)
Women's health (78)
Worklife (6)
Date
Today (1)
Last 7 days (525)
Last 30 days (1962)
Last 365 days (27092)
2026 (2541)
2025 (27428)
2024 (30006)
2023 (33364)
2022 (41434)
2021 (43287)
2020 (39941)
2019 (30883)
2018 (23289)
2017 (24008)
2016 (21915)
2015 (25667)
2014 (18537)
2013 (13916)
2012 (14574)
2011 (14995)
2010 (14067)
Location
Africa (387)
Alabama (75)
Alaska (3)
Arizona (174)
Arkansas (11)
Asia (29325)
Australia (5673)
California (10354)
Canada (2654)
China (1034)
Colorado (407)
Connecticut (447)
Delaware (318)
Europe (67119)
Florida (1397)
Georgia (314)
Hawaii (3)
Idaho (42)
Illinois (658)
India (44)
Indiana (412)
Iowa (17)
Japan (405)
Kansas (98)
Kentucky (35)
Louisiana (19)
Maine (27)
Maryland (1110)
Massachusetts (7408)
Michigan (207)
Minnesota (421)
Mississippi (4)
Missouri (97)
Montana (30)
Nebraska (17)
Nevada (105)
New Hampshire (66)
New Jersey (2653)
New Mexico (24)
New York (2676)
North Carolina (1245)
North Dakota (6)
Northern California (5065)
Ohio (282)
Oklahoma (22)
Oregon (36)
Pennsylvania (1939)
Puerto Rico (15)
Rhode Island (28)
South America (504)
South Carolina (44)
Southern California (4061)
Tennessee (144)
Texas (1634)
United States (35260)
Utah (273)
Vermont (1)
Virginia (225)
Washington D.C. (55)
Washington State (828)
West Virginia (2)
Wisconsin (106)
Wyoming (1)
480,444 Results for "4g clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
January 5, 2026
·
17 min read
Press Releases
CMS Assigns HCPCS Level II Code A2037 to Gel4Med’s G4Derm™ Plus
August 28, 2025
·
1 min read
BioMidwest
Humhealth Unveils Remote Patient Monitoring With Advanced 4G Device Configuration and 4G Watch
Humhealth, a leading provider of innovative remote care solutions, has the capability to integrate with an advanced 4G Telehealth Gateway Hub and 4G vital monitoring devices.
May 1, 2024
·
3 min read
Press Releases
IVOS Medical Joins NIH’s C3i Program to Accelerate Commercialization of BOSS G4™ Airway Management Technology
September 11, 2025
·
2 min read
Press Releases
Gel4Med and Spartan Medical Partner to Supply G4Derm™ Plus and Suprello™ to VA and DoD Medical Facilities Nationwide
July 2, 2025
·
1 min read
Press Releases
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics
January 27, 2026
·
4 min read
Press Releases
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities
January 20, 2026
·
3 min read
FDA Grants Clearance to Gel4Med: Breakthroughs in Wound Management with G4Derm and G4Derm Plus
Gel4Med, an innovative biomaterials company, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its first biosynthetic matrix products, G4Derm and G4Derm Plus.
October 23, 2023
·
3 min read
Press Releases
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
January 12, 2026
·
11 min read
Deals
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2024
G1 Therapeutics, Inc. today announced the grant of inducement stock options exercisable for 4,650 shares of G1’s common stock and 2,400 restricted stock units (RSUs) to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Amended and Restated 2021 Plan”).
June 5, 2024
·
2 min read
1 of 48,045
Next
